Financhill
Back

Theriva Biologics Quote, Financials, Valuation and Earnings

Theriva Biologics Price Quote

$0.45
-0.02 (-7.12%)
(Updated: March 29, 2024 at 6:55 AM ET)

Theriva Biologics Key Stats

Sell
32
Theriva Biologics (TOVX) is a Sell

Day range:
$0.44 - $0.49
52-week range:
$0.20 - $1.20
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.22%

Volume:
42.3K
Avg. volume:
142.4K
1-year change:
-27.85%
Market cap:
$8M
Revenue:
$0
EPS:
$-1.16

How Much Does Theriva Biologics Make?

Data Unavailable

Is Theriva Biologics Growing As A Company?

Data Unavailable

Theriva Biologics Stock Price Performance

What Is Theriva Biologics 52-Week High & Low?

Theriva Biologics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Theriva Biologics?

  • How Much Debt Does Theriva Biologics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Theriva Biologics Have?
    Cash and short term investments quarterly total is $23.2M
  • What Is Theriva Biologics’s Book Value Per Share?
    Book value per share is 2.17

Is Theriva Biologics Cash Flow Positive?

  • What Is TOVX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$19M
  • What Is Theriva Biologics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $625K
  • What Is Theriva Biologics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$202K

Theriva Biologics Return On Invested Capital

Data Unavailable

Theriva Biologics Earnings Date & Stock Price

Theriva Biologics Competitors

  • Who Are Theriva Biologics's Competitors?
    Below is a list of companies who compete with Theriva Biologics or are related in some way:
    • Ampio Pharmaceuticals Inc (AMPE)
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Oragenics Inc (OGEN)
    • Palatin Technologies Inc (PTN)

Theriva Biologics Dividend Yield

Data Unavailable

Theriva Biologics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 4.50
Upside from Last Price: 859.49%

Major Shareholders

  • How many TOVX shares are owned by institutional investors?
    1.2M TOVX shares are owned by institutional investors
  • How many TOVX shares are owned by insiders?
    6.6M TOVX shares are owned by insiders